Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Summary: Background: Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence from randomised controlled trials (RCTs). Methods: REACT (Real world effectiveness in allergy immunotherapy)...
Saved in:
Main Authors: | Benedikt Fritzsching (Author), Marco Contoli (Author), Celeste Porsbjerg (Author), Sarah Buchs (Author), Julie Rask Larsen (Author), Lisa Elliott (Author), Mercedes Romano Rodriguez (Author), Nick Freemantle (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma - Authors´ reply
by: Benedikt Fritzsching, et al.
Published: (2022) -
High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
by: Benedikt Fritszching, et al.
Published: (2023) -
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma
by: Siddhesh Kamat, et al.
Published: (2022) -
Immunotherapy and probiotic treatment for allergic rhinitis in children
by: Sumadiono Sumadiono, et al.
Published: (2018) -
Degree of fear of needles and preferred allergy immunotherapy treatment among children with allergic rhinitis: caregiver survey results
by: Karen Rance, et al.
Published: (2024)